Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Schizophrenia and Acute Agitation”

9 trials

Showing 9 of 9 results

Not applicableStudy completedNCT00631722
What this trial is testing

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

Who this might be right for
Schizophrenia
Peking University 80
Post-approval studies (Phase 4)Study completedNCT01400113
What this trial is testing

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

Who this might be right for
Agitation
Unity Health Toronto 120
Large-scale testing (Phase 3)Study completedNCT00628589
What this trial is testing

Staccato Loxapine in Agitated Patients With Schizophrenia

Who this might be right for
Patients With Schizophrenia and Acute Agitation
Alexza Pharmaceuticals, Inc. 344
Large-scale testing (Phase 3)Study completedNCT00970281
What this trial is testing

Olanzapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 91
Post-approval studies (Phase 4)UnknownNCT00838032
What this trial is testing

Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

Who this might be right for
Acute Schizophrenia
Sichuan University 70
Post-approval studies (Phase 4)Study completedNCT01050478
What this trial is testing

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Who this might be right for
Psychomotor AgitationAcute Disease
Janssen Cilag N.V./S.A. 56
Post-approval studies (Phase 4)Study completedNCT00954122
What this trial is testing

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 35
Large-scale testing (Phase 3)UnknownNCT05803642
What this trial is testing

Olanzapine in Patients With Acute Agitation

Who this might be right for
Acute Agitation
Qilu Pharmaceutical Co., Ltd. 318
Large-scale testing (Phase 3)Study completedNCT00136994
What this trial is testing

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation